Abstract:
Reliable, timely, and evidence-based drug information (DI) is vital to patient safety, rational
medicine use, and regulatory decision-making. In Ethiopia, gaps in access to high-quality DI
Services (DIS) contribute to avoidable adverse drug events, and inefficient use of limited health
resources. Strengthening DIS is therefore a national priority.
